EMERGING CV RISK FACTORS NOW ONLINE
The Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke Laboratory Medicine Practice Guideline, edited by Gary L. Myers is now available on the NACB web site.
Heart disease and stroke continue to be the leading causes of death in the United States. As a result, investigators continue to look for new and emerging biomarkers of disease risk. Because many of these emerging biomarkers are not as well documented as those of conventional lipid and lipoprotein risk factors, their value in clinical practice needs to be critically appraised and appropriate guidelines developed for their proposed use.
The NACB Board would like to thank the following committee members for their hard work and dedication: Gary L. Myers, Robert H. Christenson, Christie M. Ballantyne, Gerald R. Cooper, Mary Cushman, Scott M. Grundy, Darwin R. Labarthe, Daniel Levy, Nader Rifai, and Peter W.F. Wilson.
Back to News & Views